Wei, Lihong
Wei, Lihong was paid $1.19M by Medicaid between Jan 2018 and Nov 2024, across 39 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 35% of everything it billed.
33Billing provider infoWEI, LIHONG
FRESH MEADOWS, NY 11366
FRESH MEADOWS, NY 11366
33aNPI1861574576assigned 10/20/2006
33bProvider typeSpecialist
28Total paid$1.19M
24GClaims59,272
24DCodes billed39
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Specialist providers in New York
Rank by total paid#133 of 1,221
Median peer was paid$45K
This provider vs. median26×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 8,401 | $148K | |
| 2019 | 15,896 | $328K | |
| 2020 | 6,550 | $109K | |
| 2021 | 8,828 | $143K | |
| 2022 | 9,406 | $183K | |
| 2023 | 7,207 | $194K | |
| 2024incomplete | 2,984 | $87K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 35% | 11,685 | 9,427 | $419K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 20% | 9,115 | 8,443 | $233K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 14% | 3,118 | 1,615 | $171K |
| J0897 | Injection, denosumab, 1 mg | 8.4% | 223 | 200 | $101K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 4.0% | 1,775 | 929 | $48K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.9% | 6,457 | 5,211 | $35K |
| 96367 | 2.8% | 1,561 | 773 | $33K | |
| J2469 | Injection, palonosetron hcl, 25 mcg | 2.1% | 991 | 513 | $25K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.8% | 11,821 | 8,677 | $21K |
| 96417 | 1.7% | 518 | 285 | $20K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.5% | 1,536 | 780 | $18K |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 1.5% | 165 | 107 | $18K |
27 more codes
| J1756 | Injection, iron sucrose, 1 mg | 1.2% | 578 | $14K |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | <1% | 61 | $5K |
| 99442 | <1% | 221 | $4K | |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | <1% | 35 | $4K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 58 | $4K |
| 96415 | <1% | 103 | $3K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 53 | $3K |
| 99443 | <1% | 51 | $3K | |
| 99205 | Prolong outpt/office vis | <1% | 39 | $3K |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 4,092 | $2K |
| J9045 | Injection, carboplatin, 50 mg | <1% | 121 | $1K |
| 96368 | <1% | 76 | $922.76 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,783 | $698.80 |
| 96401 | <1% | 14 | $483.39 | |
| 96402 | <1% | 36 | $416.99 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,542 | $401.26 |
| 99441 | <1% | 14 | $314.42 | |
| 99497 | <1% | 15 | $250.27 | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 17 | $238.19 |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 23 | $227.57 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 161 | $152.86 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 287 | $132.61 |
| 81000 | <1% | 88 | $111.62 | |
| J3490 | Unclassified drugs | <1% | 208 | $107.08 |
| J3480 | Injection, potassium chloride, per 2 meq | <1% | 121 | $90.93 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 123 | $42.55 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 0% | 387 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.